San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma
Venue: Sheraton San Diego Resort, San Diego, CA, United States
Official conference page for San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma. https://binaytara.org/projects/conferences/san-diego-hematologic-malignancies-symposium
About San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Saturday, September 19th, 2026
All timings are in Pacific Time (PDT, GMT-07:00) time.
Session Chair: Vinod Pullarkat, MD
08:05 AM - 08:20 AM
Evolving Strategies in Acute Leukemias – Vinod Pullarkat, MD
08:20 AM - 08:25 AM
Evolving Strategies in Acute Leukemias (Q&A)
08:25 AM - 08:35 AM
Case 1: Newly diagnosed FLT3+ AML - To Transplant or Not – Tiffany Nicole Tanaka, MD
08:45 AM - 08:55 AM
Case 2: R/R ALL in a young adult — CAR-T vs BiTE vs salvage chemo OR Relapsed/refractory B-ALL – Sequencing of novel immunotherapies – Tamer Othman, MD, MD
08:55 AM - 09:15 AM
Case-Based Discussion
Moderators:
Vinod Pullarkat, MD
Panelists:
Tamer Othman, MD, MD; Tiffany Nicole Tanaka, MD
Session Chair: Kentson Lam, MD PhD
09:15 AM - 09:30 AM
Modern Management of MDS and MPNs – Ling Huang
09:30 AM - 09:35 AM
Modern Management of MDS and MPNs (Q&A)
09:35 AM - 09:45 AM
Case: MDS/MPNs - Case Presenter TBD
09:45 AM - 10:00 AM
Case-Based Discussion
Moderators:
Kentson Lam, MD PhD
Panelists:
Ling Huang ; Kristin Elo
Session Chair: Caitlin Costello, MD
10:45 AM - 11:00 AM
Emerging Therapies in Multiple Myeloma – Caitlin Costello, MD
11:00 AM - 11:05 AM
Emerging Therapies in Multiple Myeloma (Q&A)
11:05 AM - 11:15 AM
Case 1 - NDMM - role of transplant? PERSEUS vs CEPHEUS – Lisa Lee, MD
11:15 AM - 11:25 AM
Case 2: Early Relapse: CART vs. Bispecific – Sarah S Lee, MD, MD
11:25 AM - 11:40 AM
Case-Based Discussion
Moderators:
Caitlin Costello, MD
Panelists:
Aaron S Rosenberg, MD; Lisa Lee ; Sarah S Lee, MD, MD
Session Chair: Reema Batra , MD
01:00 PM - 01:15 PM
Current Approaches to R/R Disease – Marin Xavier, MD
01:15 PM - 01:20 PM
Current Approaches to R/R Disease (Q&A)
01:20 PM - 01:30 PM
Case 1: Double-hit DLBCL – Is intensified chemo (DA-EPOCH-R) still standard? – Reema Batra , MD
01:30 PM - 01:40 PM
Case 2: Primary refractory DLBCL – CAR-T vs. Bispecifics – Autumn Jeong, MD
01:40 PM - 02:00 PM
Case-Based Discussion
Moderators:
Reema Batra , MD
Panelists:
Autumn Jeong, MD; Geoffrey Shouse, DO, PhD; Marin Xavier, MD
Session Chair: Bita Fakhri, MD, MPH
02:15 PM - 02:30 PM
How I Treat CLL: Practical Decision-Making – Michael Choi, MD
02:30 PM - 02:35 PM
How I Treat CLL: Practical Decision-Making (Q&A)
02:35 PM - 02:45 PM
Case: CLL – Catherine Coombs, MD
02:45 PM - 03:00 PM
Case-Based Discussion
Moderators:
Bita Fakhri, MD, MPH
Panelists:
Michael Choi, MD; Catherine Coombs, MD
Session Chair: Benjamin Heyman, MD
03:00 PM - 03:15 PM
Optimizing Treatment Strategies in Low-Grade Lymphomas – Paul Cheng, MD
03:15 PM - 03:20 PM
Optimizing Treatment Strategies in Low-Grade Lymphomas (Q&A)
03:20 PM - 03:30 PM
Case: Low-grade Lymphomas – Benjamin Heyman, MD
03:30 PM - 03:45 PM
Case-Based Discussion
Moderators:
Benjamin Heyman, MD
Panelists:
Paul Cheng, MD
